Orlando nightclub shooter feared slipping into psychosis and was obsessed with researching psychotropic drugs online, says acquaintance

Sunday, July 03, 2016 by: J. D. Heyes
Tags: Omar Mateen, Orlando nightclub shooting, psychotropic drugs

---

(NaturalNews) Scores of Americans are still in shock over the horrific terrorist attack in Orlando, Fla., in which a lone jihadi walked into a gay nightclub and spent the next several hours gunning down patrons.

As investigators continue to look into the attack, additional information is beginning to emerge, including this tidbit: Prior to his attack, terrorist gunman Omar Mateen stayed up all night to research anti-psychotic medications.

Now, why would he do that?

Perhaps to give the appearance that he might not be a "soldier of ISIS" as he claimed to be in a phone call to authorities while the attack was still in progress. And maybe it was to give the American media something to chew on and regurgitate as most mainstream media outlets looked for any reason not to blame the terrorism on Islam.

Psychosis not clear – was Mateen's search of anti-psychotic meds just a ruse?

As Reuters reported, Mateen told an acquaintance that the night before the attack he stayed up all night researching anti-psychotic medications. That was plenty of "evidence" for the Reuters reporter and a number of Obama administration officials to surmise:

The FBI would not comment on the acquaintance's remarks, but several senior U.S. sources told Reuters the investigation was moving more toward the belief that Mateen's motives were personal rather than political.

"It looks increasingly like this may have been the act of a seriously troubled individual whose personal problems dwarfed any last-minute inspiration from radical groups," said a senior U.S. official familiar with the investigation, speaking on condition of anonymity.

Well, that would be simple, wouldn't it – that is, simple for anyone who doesn't want to say that radical Islam was responsible for the attack. Blame it on the meds.

After all, it's not like other mass murderers were not affected by anti-depressants and other mood-altering medications, as noted at PsychDrugShooters.com. There, you will find a wealth of information about past mass murderers in the U.S., all with the common theme of "medication."

But, that doesn't sound like Mateen. With a jihadi, what others try to pass off as erratic, unstable behavior may simply be the actions of a cold, calculating terrorist. And why is that so hard to believe?

Then again, as noted by the acquaintance – who professed that he did not know Mateen all that well – he witnessed some changes in Mateen's personality in the weeks leading up to the attacks. About three weeks before the attacks, the acquaintance passed through the security gate where Mateen worked, and when the Afghan descendant appeared agitated, the acquaintance asked if he was okay.

Pledged allegiance to ISIS

"The last month, he looked worried, he looked upset, he looked confused," the acquaintance said. "He didn't seem himself."

"He'd been real worried about whether or not he'd slipped into psychosis," the acquaintance told Reuters. "He wasn't as friendly. He was obsessed with researching medication online."

As noted by Zero Hedge, in the early morning, about 18 hours before the June 12 attack, the acquaintance said he noticed that Mateen was not there as he usually was to open the gate. He appeared a couple of minutes later and was silent, with a completely transformed look: A shaved head and face, minus his usual short beard and glasses. When the acquaintance asked about him, Mateen responded: "What's it to you, anyway?"

Obviously this paints a picture of a Mateen whose mental condition may have been deteriorating. He had discipline problems, and he had been kicked out of a police academy. But could this perhaps be the behavior of a man who was becoming more radicalized and preparing himself mentally to commit a heinous act of terrorism?

In the end, medication or not, Mateen pledged allegiance to ISIS during his attack.

Sources:

CNN.com

ZeroHedge.com

Reuters.com